What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?
Identifieur interne : 000105 ( PubMed/Curation ); précédent : 000104; suivant : 000106What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?
Auteurs : Sergio Rosales-Mendoza [Mexique] ; Ver Nica A. Márquez-Escobar [Mexique] ; Omar González-Ortega [Mexique] ; Ricardo Nieto-G Mez [Mexique] ; Jaime I. Arévalo-Villalobos [Mexique]Source :
- Vaccines [ 2076-393X ] ; 2020.
Abstract
The emergence of new pathogenic viral strains is a constant threat to global health, with the new coronavirus strain COVID-19 as the latest example. COVID-19, caused by the SARS-CoV-2 virus has quickly spread around the globe. This pandemic demands rapid development of drugs and vaccines. Plant-based vaccines are a technology with proven viability, which have led to promising results for candidates evaluated at the clinical level, meaning this technology could contribute towards the fight against COVID-19. Herein, a perspective in how plant-based vaccines can be developed against COVID-19 is presented. Injectable vaccines could be generated by using transient expression systems, which offer the highest protein yields and are already adopted at the industrial level to produce VLPs-vaccines and other biopharmaceuticals under GMPC-processes. Stably-transformed plants are another option, but this approach requires more time for the development of antigen-producing lines. Nonetheless, this approach offers the possibility of developing oral vaccines in which the plant cell could act as the antigen delivery agent. Therefore, this is the most attractive approach in terms of cost, easy delivery, and mucosal immunity induction. The development of multiepitope, rationally-designed vaccines is also discussed regarding the experience gained in expression of chimeric immunogenic proteins in plant systems.
DOI: 10.3390/vaccines8020183
PubMed: 32295153
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000105
Links to Exploration step
pubmed:32295153Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?</title>
<author><name sortKey="Rosales Mendoza, Sergio" sort="Rosales Mendoza, Sergio" uniqKey="Rosales Mendoza S" first="Sergio" last="Rosales-Mendoza">Sergio Rosales-Mendoza</name>
<affiliation wicri:level="1"><nlm:affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Marquez Escobar, Ver Nica A" sort="Marquez Escobar, Ver Nica A" uniqKey="Marquez Escobar V" first="Ver Nica A" last="Márquez-Escobar">Ver Nica A. Márquez-Escobar</name>
<affiliation wicri:level="1"><nlm:affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gonzalez Ortega, Omar" sort="Gonzalez Ortega, Omar" uniqKey="Gonzalez Ortega O" first="Omar" last="González-Ortega">Omar González-Ortega</name>
<affiliation wicri:level="1"><nlm:affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Nieto G Mez, Ricardo" sort="Nieto G Mez, Ricardo" uniqKey="Nieto G Mez R" first="Ricardo" last="Nieto-G Mez">Ricardo Nieto-G Mez</name>
<affiliation wicri:level="1"><nlm:affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Arevalo Villalobos, Jaime I" sort="Arevalo Villalobos, Jaime I" uniqKey="Arevalo Villalobos J" first="Jaime I" last="Arévalo-Villalobos">Jaime I. Arévalo-Villalobos</name>
<affiliation wicri:level="1"><nlm:affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32295153</idno>
<idno type="pmid">32295153</idno>
<idno type="doi">10.3390/vaccines8020183</idno>
<idno type="wicri:Area/PubMed/Corpus">000105</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000105</idno>
<idno type="wicri:Area/PubMed/Curation">000105</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000105</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?</title>
<author><name sortKey="Rosales Mendoza, Sergio" sort="Rosales Mendoza, Sergio" uniqKey="Rosales Mendoza S" first="Sergio" last="Rosales-Mendoza">Sergio Rosales-Mendoza</name>
<affiliation wicri:level="1"><nlm:affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Marquez Escobar, Ver Nica A" sort="Marquez Escobar, Ver Nica A" uniqKey="Marquez Escobar V" first="Ver Nica A" last="Márquez-Escobar">Ver Nica A. Márquez-Escobar</name>
<affiliation wicri:level="1"><nlm:affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Gonzalez Ortega, Omar" sort="Gonzalez Ortega, Omar" uniqKey="Gonzalez Ortega O" first="Omar" last="González-Ortega">Omar González-Ortega</name>
<affiliation wicri:level="1"><nlm:affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Nieto G Mez, Ricardo" sort="Nieto G Mez, Ricardo" uniqKey="Nieto G Mez R" first="Ricardo" last="Nieto-G Mez">Ricardo Nieto-G Mez</name>
<affiliation wicri:level="1"><nlm:affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Arevalo Villalobos, Jaime I" sort="Arevalo Villalobos, Jaime I" uniqKey="Arevalo Villalobos J" first="Jaime I" last="Arévalo-Villalobos">Jaime I. Arévalo-Villalobos</name>
<affiliation wicri:level="1"><nlm:affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</nlm:affiliation>
<country xml:lang="fr">Mexique</country>
<wicri:regionArea>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">Vaccines</title>
<idno type="ISSN">2076-393X</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The emergence of new pathogenic viral strains is a constant threat to global health, with the new coronavirus strain COVID-19 as the latest example. COVID-19, caused by the SARS-CoV-2 virus has quickly spread around the globe. This pandemic demands rapid development of drugs and vaccines. Plant-based vaccines are a technology with proven viability, which have led to promising results for candidates evaluated at the clinical level, meaning this technology could contribute towards the fight against COVID-19. Herein, a perspective in how plant-based vaccines can be developed against COVID-19 is presented. Injectable vaccines could be generated by using transient expression systems, which offer the highest protein yields and are already adopted at the industrial level to produce VLPs-vaccines and other biopharmaceuticals under GMPC-processes. Stably-transformed plants are another option, but this approach requires more time for the development of antigen-producing lines. Nonetheless, this approach offers the possibility of developing oral vaccines in which the plant cell could act as the antigen delivery agent. Therefore, this is the most attractive approach in terms of cost, easy delivery, and mucosal immunity induction. The development of multiepitope, rationally-designed vaccines is also discussed regarding the experience gained in expression of chimeric immunogenic proteins in plant systems.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">32295153</PMID>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>16</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN>
<JournalIssue CitedMedium="Print"><Volume>8</Volume>
<Issue>2</Issue>
<PubDate><Year>2020</Year>
<Month>Apr</Month>
<Day>14</Day>
</PubDate>
</JournalIssue>
<Title>Vaccines</Title>
<ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation>
</Journal>
<ArticleTitle>What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19?</ArticleTitle>
<ELocationID EIdType="pii" ValidYN="Y">E183</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines8020183</ELocationID>
<Abstract><AbstractText>The emergence of new pathogenic viral strains is a constant threat to global health, with the new coronavirus strain COVID-19 as the latest example. COVID-19, caused by the SARS-CoV-2 virus has quickly spread around the globe. This pandemic demands rapid development of drugs and vaccines. Plant-based vaccines are a technology with proven viability, which have led to promising results for candidates evaluated at the clinical level, meaning this technology could contribute towards the fight against COVID-19. Herein, a perspective in how plant-based vaccines can be developed against COVID-19 is presented. Injectable vaccines could be generated by using transient expression systems, which offer the highest protein yields and are already adopted at the industrial level to produce VLPs-vaccines and other biopharmaceuticals under GMPC-processes. Stably-transformed plants are another option, but this approach requires more time for the development of antigen-producing lines. Nonetheless, this approach offers the possibility of developing oral vaccines in which the plant cell could act as the antigen delivery agent. Therefore, this is the most attractive approach in terms of cost, easy delivery, and mucosal immunity induction. The development of multiepitope, rationally-designed vaccines is also discussed regarding the experience gained in expression of chimeric immunogenic proteins in plant systems.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rosales-Mendoza</LastName>
<ForeName>Sergio</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Sección de Biotecnología, Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, Av. Sierra Leona 550, Lomas 2ª Sección, San Luis Potosí 78210, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Márquez-Escobar</LastName>
<ForeName>Verónica A</ForeName>
<Initials>VA</Initials>
<AffiliationInfo><Affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Sección de Biotecnología, Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, Av. Sierra Leona 550, Lomas 2ª Sección, San Luis Potosí 78210, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>González-Ortega</LastName>
<ForeName>Omar</ForeName>
<Initials>O</Initials>
<Identifier Source="ORCID">0000-0002-5878-8078</Identifier>
<AffiliationInfo><Affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Nieto-Gómez</LastName>
<ForeName>Ricardo</ForeName>
<Initials>R</Initials>
<AffiliationInfo><Affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Sección de Biotecnología, Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, Av. Sierra Leona 550, Lomas 2ª Sección, San Luis Potosí 78210, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Arévalo-Villalobos</LastName>
<ForeName>Jaime I</ForeName>
<Initials>JI</Initials>
<AffiliationInfo><Affiliation>Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, San Luis Potosí 78210, Mexico.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Sección de Biotecnología, Centro de Investigación en Ciencias de la Salud y Biomedicina, Universidad Autónoma de San Luis Potosí, Av. Sierra Leona 550, Lomas 2ª Sección, San Luis Potosí 78210, Mexico.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>PRODEP-2020</GrantID>
<Agency>Consejo Nacional de Ciencia y Tecnología</Agency>
<Country></Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>04</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>Switzerland</Country>
<MedlineTA>Vaccines (Basel)</MedlineTA>
<NlmUniqueID>101629355</NlmUniqueID>
<ISSNLinking>2076-393X</ISSNLinking>
</MedlineJournalInfo>
<KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">epitope-based vaccine</Keyword>
<Keyword MajorTopicYN="N">molecular farming</Keyword>
<Keyword MajorTopicYN="N">mucosal immunization</Keyword>
<Keyword MajorTopicYN="N">multiepitope vaccine</Keyword>
<Keyword MajorTopicYN="N">oral vaccines</Keyword>
<Keyword MajorTopicYN="N">zoonosis</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>03</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2020</Year>
<Month>04</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>04</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>4</Month>
<Day>17</Day>
<Hour>6</Hour>
<Minute>1</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32295153</ArticleId>
<ArticleId IdType="pii">vaccines8020183</ArticleId>
<ArticleId IdType="doi">10.3390/vaccines8020183</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000105 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 000105 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= SrasV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:32295153 |texte= What Does Plant-Based Vaccine Technology Offer to the Fight against COVID-19? }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:32295153" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a SrasV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |